1. Coronavirus disease (COVID‐19): An updated review based on current knowledge and existing literature for dermatologists. Issue 4 (26th June 2020) Authors: Kaur, Ishmeet; Sharma, Aseem; Jakhar, Deepak; Das, Anupam; Aradhya, Sujala Sacchidanand; Sharma, Rashmi; Jindal, Veenu; Mhatre, Madhulika Journal: Dermatologic therapy Issue: Volume 33:Issue 4(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Endemic leprosy, scarcity of clofazimine in pharmacies, and the ensuing therapeutic void. Issue 1 (24th November 2020) Authors: Sharma, Aseem; Pai, Vivek V.; Mhatre, Madhulika Journal: Dermatologic therapy Issue: Volume 34:Issue 1(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Micropigmentation—A revived therapeutic tool for recalcitrant, difficult‐to‐treat periungual vitiligo. Issue 4 (4th June 2020) Authors: Sharma, Aseem; Agrawal, Sandip; Dhurat, Rachita; Mhatre, Madhulika; Surve, Ravina; Kerure, Amit Journal: Dermatologic therapy Issue: Volume 33:Issue 4(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The COVID‐19 chemoprophylactic conundrum: Are we limiting available resources?. Issue 4 (9th June 2020) Authors: Sharma, Aseem; Mhatre, Madhulika; Goldust, Mohamad; Jindal, Veenu; Singla, Palvi Journal: Dermatologic therapy Issue: Volume 33:Issue 4(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Will teledermatology be the silver lining during and after COVID‐19?. Issue 4 (4th June 2020) Authors: Sharma, Aseem; Jindal, Veenu; Singla, Palvi; Goldust, Mohamad; Mhatre, Madhulika Journal: Dermatologic therapy Issue: Volume 33:Issue 4(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗